Vor Biopharma Stock Options
| VOR Stock | USD 2.05 0.16 7.24% |
Vor Biopharma's latest option contracts expiring on October 17th 2025 are carrying combined implied volatility of 2.16 with a put-to-call open interest ratio of 0.09 over 16 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on October 17th 2025. The total put volume is at 109, with calls trading at the volume of 479. This yields a 0.23 put-to-call volume ratio.
Open Interest Against October 17th 2025 Option Contracts
2025-10-17
The chart above shows Vor Biopharma's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Vor Biopharma's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Vor Biopharma's option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Vor Biopharma
Analyzing Vor Biopharma's in-the-money options over time can help investors to take a profitable long position in Vor Biopharma regardless of its overall volatility. This is especially true when Vor Biopharma's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Vor Biopharma's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Vor Biopharma's stock while costing only a fraction of its price.
Vor Biopharma In The Money Call Balance
When Vor Biopharma's strike price is surpassing the current stock price, the option contract against Vor Biopharma stock is said to be in the money. When it comes to buying Vor Biopharma's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Vor Biopharma are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Vor Current Options Market Mood
Vor Biopharma's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Vor Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Vor Biopharma's options investors are not very successful. Vor Biopharma's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Vor contract
Base on the Rule 16, the options market is currently suggesting that Vor Biopharma will have an average daily up or down price movement of about 0.14% per day over the life of the 2025-10-17 option contract. With Vor Biopharma trading at USD 2.05, that is roughly USD 0.002768. If you think that the market is fully incorporating Vor Biopharma's daily price movement you should consider buying Vor Biopharma options at the current volatility level of 2.16%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing Vor Biopharma options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Vor calls. Remember, the seller must deliver Vor Biopharma stock to the call owner when a call is exercised.
Vor Biopharma Option Chain
When Vor Biopharma's strike price is surpassing the current stock price, the option contract against Vor Biopharma stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Vor Biopharma's option chain is a display of a range of information that helps investors for ways to trade options on Vor. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Vor. It also shows strike prices and maturity days for a Vor Biopharma against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | VOR251017C00006000 | 8 | 6.0 | 0.0 - 0.55 | 0.1 | Out |
Call | VOR251017C00005000 | 164 | 5.0 | 0.0 - 0.15 | 0.15 | Out |
Call | VOR251017C00004000 | 5526 | 4.0 | 0.05 - 0.15 | 0.15 | Out |
Call | VOR251017C00003000 | 20551 | 3.0 | 0.15 - 0.2 | 0.18 | Out |
Call | VOR251017C00002000 | 52850 | 2.0 | 0.3 - 0.4 | 0.3 | In |
Call | VOR251017C00001500 | 2 | 1.5 | 0.0 - 0.95 | 1.0 | In |
Call | VOR251017C00001000 | 463 | 1.0 | 0.75 - 1.25 | 1.0 | In |
Call | VOR251017C00000500 | 0 | 0.5 | 1.15 - 1.8 | 1.15 | In |
Put | VOR251017P00006000 | 0 | 6.0 | 4.0 - 4.7 | 4.0 | In |
Put | VOR251017P00005000 | 0 | 5.0 | 3.1 - 4.1 | 3.1 | In |
Put | VOR251017P00004000 | 13 | 4.0 | 2.2 - 2.85 | 2.45 | In |
Put | VOR251017P00003000 | 2568 | 3.0 | 1.3 - 1.9 | 1.64 | In |
Put | VOR251017P00002000 | 2517 | 2.0 | 0.5 - 0.75 | 0.71 | Out |
Put | VOR251017P00001500 | 41 | 1.5 | 0.25 - 0.35 | 0.32 | Out |
Put | VOR251017P00001000 | 2284 | 1.0 | 0.1 - 0.15 | 0.15 | Out |
Put | VOR251017P00000500 | 0 | 0.5 | 0.0 - 0.3 | 0.3 |
Vor Total Stockholder Equity
Total Stockholder Equity |
|
Vor Biopharma Corporate Management
| PharmD D | Chief Officer | Profile | |
| Samir MS | Senior Management | Profile | |
| Han MD | Chief Officer | Profile | |
| Dr MBA | Chief Officer | Profile | |
| Eyal MD | Former Officer | Profile | |
| Tania Philipp | Chief Officer | Profile | |
| MBA MD | CEO Pres | Profile |
Additional Tools for Vor Stock Analysis
When running Vor Biopharma's price analysis, check to measure Vor Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vor Biopharma is operating at the current time. Most of Vor Biopharma's value examination focuses on studying past and present price action to predict the probability of Vor Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vor Biopharma's price. Additionally, you may evaluate how the addition of Vor Biopharma to your portfolios can decrease your overall portfolio volatility.